3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
HIV Infections
2
Sarcoma, Kaposi
1
Lymphoma, AIDS-Related
1
Dendritic Cell Sarcoma, Interdigitating
1
Acquired Immunodeficiency Syndrome
1
Interventions
Etoposide
4
Cyclophosphamide
3
Vincristine
2
Rituximab
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Cytarabine
2
Carmustine
2
efavirenz
1
VAP-cyclo protocol
1
Radiotherapy
1
Procarbazine
1
Ondansetron
1
O(6)-benzylguanine
1
Lomustine
1
Genes
1
Filgrastim
1
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
Doxorubicin
1
Aprepitant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, AIDS-Related
×
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
×
Clear all
NCT00799136
2013-09-12
CATCH
Ontario Clinical Oncology Group (OCOG)
Phase 2
Completed
6 enrolled